USP11 levels in females are also strongly associated with tau pathology, and the inhibition of USP11-mediated deubiquitination of tau protein may provide an effective therapeutic approach to protect females from increased susceptibility to AD and other tauopathies [136]. Here, MAPT is linked to tauopathy.